Global Hepatitis B Vaccines Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Hepatitis B Vaccines Market was valued at $8.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.1% CAGR, to an estimated market size of $11.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global hepatitis B vaccine market includes biological preparations designed to prevent infection by the Hepatitis B virus (HBV) and its associated complications like cirrhosis and liver cancer. The scope encompasses both monovalent (single-antigen) and multivalent (combination) vaccines, such as hexavalent formulations, administered through pediatric and adult immunization programs. It excludes therapeutic antiviral drugs and interferon therapies.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Hepatitis B Vaccines Market in the period 2025-30:
- Rapid adoption of combination vaccines (e.g., hexavalent) that protect against multiple diseases in a single dose to improve patient compliance and logistics.
- Widespread implementation of universal infant immunization programs and mandatory birth-dose policies driven by WHO and national health ministries.
- Expansion of adult vaccination recommendations, such as the CDC's updated guidelines for adults aged 19 to 59, increasing the addressable market.
- Technological transition toward prefilled syringes and needle-free delivery systems to enhance mass immunization efficiency and reduce healthcare waste.
- Increased funding and co-financing from global organizations like Gavi, the Vaccine Alliance to stabilize demand and accessibility in low-income regions.
- Strategic shift in manufacturing toward recombinant DNA technology and novel adjuvants to enhance vaccine immunogenicity and safety profiles.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Combination Vaccines
- Single Antigen Vaccines